{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T15:26:59Z","timestamp":1760369219635,"version":"3.40.5"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.clinthera.2014.11.014","type":"journal-article","created":{"date-parts":[[2014,12,24]],"date-time":"2014-12-24T06:15:45Z","timestamp":1419401745000},"page":"390-401","source":"Crossref","is-referenced-by-count":10,"title":["Single- and Multiple-dose Pharmacokinetics of a Hydrocodone Bitartrate Extended-release Tablet Formulated With Abuse-deterrence Technology in Healthy, Naltrexone-blocked Volunteers"],"prefix":"10.1016","volume":"37","author":[{"given":"Mona","family":"Darwish","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronghua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Tracewell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Philmore","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Bond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2014.11.014_bib1","doi-asserted-by":"crossref","first-page":"478","DOI":"10.7326\/0003-4819-147-7-200710020-00006","article-title":"Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society","volume":"147","author":"Chou","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinthera.2014.11.014_bib2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jpain.2008.10.008","article-title":"Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain","volume":"10","author":"Chou","year":"2009","journal-title":"J Pain"},{"issue":"2 Suppl","key":"10.1016\/j.clinthera.2014.11.014_bib3","first-page":"S5","article-title":"Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians\u2019 (ASIPP) Guidelines","volume":"11","author":"Trescot","year":"2008","journal-title":"Pain Physician"},{"key":"10.1016\/j.clinthera.2014.11.014_bib4","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S0025-6196(11)60749-0","article-title":"A comparison of long- and short-acting opioids for the treatment of chronic noncancer pain: tailoring therapy to meet patient needs","volume":"84","author":"Argoff","year":"2009","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.clinthera.2014.11.014_bib5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00045391-200105000-00006","article-title":"Long-acting opioids for chronic pain: pharmacotherapeutic opportunities to enhance compliance, quality of life, and analgesia","volume":"8","author":"McCarberg","year":"2001","journal-title":"Am J Ther"},{"key":"10.1016\/j.clinthera.2014.11.014_bib6","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0149-2918(01)80109-0","article-title":"A systematic review of the associations between dose regimens and medication compliance","volume":"23","author":"Claxton","year":"2001","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2014.11.014_bib7","doi-asserted-by":"crossref","unstructured":"Amabile CM, Bowman BJ. Overview of oral modified-release opioid products for the management of chronic pain. Ann Pharmacother. 2006;40:1327\u20131335.","DOI":"10.1345\/aph.1G259"},{"key":"10.1016\/j.clinthera.2014.11.014_bib8","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/jat\/bks058","article-title":"Excretion profile of hydrocodone, hydromorphone and norhydrocodone in urine following single dose administration of hydrocodone to healthy volunteers","volume":"36","author":"Valtier","year":"2012","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.clinthera.2014.11.014_bib9","unstructured":"IMS Institute for Healthcare Informatics. The use of medicines in the United States: review of 2010. IMS Institute for Healthcare Informatics. IMS Institute for Healthcare Informatics. http:\/\/www.imshealth.com\/deployedfiles\/imshealth\/Global\/Content\/IMS%20Institute\/Static%20File\/IHII_UseOfMed_report.pdf. Accessed April 2, 2014."},{"key":"10.1016\/j.clinthera.2014.11.014_bib10","unstructured":"The American Society of Health-System Pharmacists. Hydrocodone. http:\/\/www.nlm.nih.gov\/medlineplus\/druginfo\/meds\/a601006.html. Accessed April 2, 2014."},{"key":"10.1016\/j.clinthera.2014.11.014_bib11","unstructured":"CIMA LABS, Inc. OraGuard\u2122: tamper-deterrent, alcohol-resistant extended release technology. 2012. http:\/\/www.cimalabs.com\/technology\/oraguard. Accessed March 31, 2014."},{"key":"10.1016\/j.clinthera.2014.11.014_bib12","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/j.1552-4604.1995.tb04094.x","article-title":"A bioequivalence study of oral controlled-release morphine using naltrexone blockade","volume":"35","author":"Kaiko","year":"1995","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2014.11.014_bib13","doi-asserted-by":"crossref","first-page":"383","DOI":"10.5055\/jom.2012.0138","article-title":"An open-label pharmacokinetic study of oxymorphone extended release in the presence of naltrexone in the older adult","volume":"8","author":"Pergolizzi","year":"2012","journal-title":"J Opioid Manag"},{"key":"10.1016\/j.clinthera.2014.11.014_bib14","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1177\/0091270010383858","article-title":"A randomized study of the effects of food on the pharmacokinetics of once-daily extended-release hydromorphone in healthy volunteers","volume":"51","author":"Moore","year":"2011","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2014.11.014_bib15","unstructured":"Riordan H, Newberry B, Sramek J, et al. Use of naltrexone to block opioid side effects in healthy volunteers: effects of dose and food [abstract; poster]. Presented at: the Annual Scientific Meeting of the American Pain Society; May 7\u20139, 2009; San Diego, CA."},{"key":"10.1016\/j.clinthera.2014.11.014_bib16","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1016\/j.jpain.2009.01.193","article-title":"Use of naltrexone to block opioid side effects in healthy volunteers: effects of dose and food [abstract 284]","volume":"10","author":"Cutler","year":"2009","journal-title":"J Pain"},{"key":"10.1016\/j.clinthera.2014.11.014_bib17","unstructured":"International Conference on Harmonisation Working Group. ICH Harmonised Tripartite Guideline: Guideline for Good Clinical Practice E6 (R1). International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use; June 10, 1996; Washington, DC. http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Efficacy\/E6\/E6_R1_Guideline.pdf. Accessed March 1, 2014."},{"key":"10.1016\/j.clinthera.2014.11.014_bib18","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/j.1552-4604.1997.tb04325.x","article-title":"Time of peak drug concentration after a single dose and a dose at steady state","volume":"37","author":"Greenberg","year":"1997","journal-title":"J Clin Pharmacol"},{"year":"2013","series-title":"Vicodin\u00ae (hydrocodone bitartrate and acetaminophen tablets, USP) 5 mg\/500 mg [package insert]","key":"10.1016\/j.clinthera.2014.11.014_bib19"},{"key":"10.1016\/j.clinthera.2014.11.014_bib20","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0031-6997(25)00012-2","article-title":"Endogenous and exogenous opioids in the control of gastrointestinal motility and secretion","volume":"40","author":"Kromer","year":"1988","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.clinthera.2014.11.014_bib21","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1517\/13543784.2011.563236","article-title":"Naloxone as part of a prolonged release oxycodone\/naloxone combination reduces oxycodone-induced slowing of gastrointestinal transit in healthy volunteers","volume":"20","author":"Smith","year":"2011","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.clinthera.2014.11.014_bib22","first-page":"183","article-title":"Opioid chronopharmacology: influence of timing of infusion on fentanyl\u2019s analgesic efficacy in healthy human volunteers","volume":"3","author":"Boom","year":"2010","journal-title":"J Pain Res"},{"key":"10.1016\/j.clinthera.2014.11.014_bib23","doi-asserted-by":"crossref","first-page":"351","DOI":"10.5055\/jom.2010.0032","article-title":"Steady-state pharmacokinetics of extended-release hydromorphone (OROS hydromorphone): a randomized study in healthy volunteers","volume":"6","author":"Moore","year":"2010","journal-title":"J Opioid Manag"},{"key":"10.1016\/j.clinthera.2014.11.014_bib24","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/00000542-200210000-00013","article-title":"Input characteristics and bioavailability after administration of immediate and a new extended-release formulation of hydromorphone in healthy volunteers","volume":"97","author":"Drover","year":"2002","journal-title":"Anesthesiology"},{"year":"2009","series-title":"Revia (naltrexone hydrochloride tablet, film coated) [package insert]","key":"10.1016\/j.clinthera.2014.11.014_bib25"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291814008078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291814008078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T10:21:52Z","timestamp":1747304512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291814008078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0149291814008078"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2014.11.014","relation":{},"ISSN":["0149-2918"],"issn-type":[{"type":"print","value":"0149-2918"}],"subject":[],"published":{"date-parts":[[2015,2]]}}}